In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)

RecruitingOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

June 13, 2022

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Chronic Lymphocytic Leukemia
Interventions
OTHER

[U-13C]glucose

\[U-13C\]glucose will be administered as a bolus of 8 g (grams) over 10 minutes followed by 8 g/hour continuous infusion over 2 hours . This infusion rate will allow glucose tracer to reach sufficient enrichment without causing significant metabolic perturbation such as hyperglycemia.

OTHER

[13C5]glutamine

6mg/kg of body weight of \[13C5\]glutamine will be administered as a bolus over 10 minutes (± 1 minute) followed by 6mg/kg/hr body weight continuous infusion for 2 hours through a peripheral IV catheter/line. This infusion rate will allow glutamine tracer to reach sufficient enrichment without causing significant metabolic perturbation such as hyperglycemia.

Trial Locations (1)

53705

RECRUITING

University of Wisconsin, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER